Literature DB >> 18427356

Analysis of the molecular parameters that could predict the risk of manifesting premature ovarian failure in female premutation carriers of fragile X syndrome.

Maria-Isabel Tejada1, Eva García-Alegría, Amaia Bilbao, Cristina Martínez-Bouzas, Elena Beristain, Marisa Poch, Maria A Ramos-Arroyo, Blanca López, Isabel Fernandez Carvajal, Maria-Pilar Ribate, Feliciano Ramos.   

Abstract

OBJECTIVE: To study three molecular parameters (number of CGG repeats, X-inactivation ratio, and expression of FMR1 mRNA) in premutation carriers of fragile X syndrome with and without premature ovarian failure (POF) to find differences between these two groups that could be useful in reproductive counseling.
DESIGN: A retrospective clinical and molecular genetic study of 42 known premutation carriers of fragile X syndrome aged 40 years or older, 25 with POF and 17 without. A blood sample to obtain mRNA was taken from all of them. They all lived in five autonomous communities in northern Spain.
RESULTS: Although the relationship among mRNA levels, X-inactivation ratio, and CGG repeats seems to be similar both in women with POF and in those without: in women with POF, the effect of the CGG repeats on the mRNA levels was statistically significant (P = 0.0437), but in women without POF, it was not (P = 0.0724). Moreover, we confirmed previous results on the nonlinear association between CGG repeat number and the manifestation of POF, showing that the likelihood of having POF was significantly higher with fewer than 100 CGG repeats compared with 100 or more CGG repeats (odds ratio = 13.09, P = 0.0240).
CONCLUSIONS: Our present work suggests that mRNA and X-inactivation studies in blood are not relevant in predicting POF in female premutation carriers of fragile X syndrome. However, having a permutation of fewer than 100 repeats could represent a significant risk of POF.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18427356     DOI: 10.1097/gme.0b013e3181647762

Source DB:  PubMed          Journal:  Menopause        ISSN: 1072-3714            Impact factor:   2.953


  30 in total

1.  FMR1 genotype interacts with parenting stress to shape health and functional abilities in older age.

Authors:  Marsha Mailick; Jinkuk Hong; Jan Greenberg; Leann Smith Dawalt; Mei Wang Baker; Paul J Rathouz
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2017-04-13       Impact factor: 3.568

2.  Intra-individual stability over time of standardized anti-Mullerian hormone in FMR1 premutation carriers.

Authors:  M A Spath; T B Feuth; E G Allen; A P T Smits; H G Yntema; A Geurts van Kessel; D D M Braat; S L Sherman; C M G Thomas
Journal:  Hum Reprod       Date:  2011-05-15       Impact factor: 6.918

3.  Curvilinear association of CGG repeats and age at menopause in women with FMR1 premutation expansions.

Authors:  Marsha R Mailick; Jinkuk Hong; Jan Greenberg; Leann Smith; Stephanie Sherman
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2014-10-25       Impact factor: 3.568

4.  Women who carry a fragile X premutation are biologically older than noncarriers as measured by telomere length.

Authors:  Igor Albizua; Benjamin L Rambo-Martin; Emily G Allen; Weiya He; Ashima S Amin; Stephanie L Sherman
Journal:  Am J Med Genet A       Date:  2017-09-21       Impact factor: 2.802

Review 5.  Implications of the FMR1 Premutation for Children, Adolescents, Adults, and Their Families.

Authors:  Anne Wheeler; Melissa Raspa; Randi Hagerman; Marsha Mailick; Catharine Riley
Journal:  Pediatrics       Date:  2017-06       Impact factor: 7.124

Review 6.  Fragile X premutation in women: recognizing the health challenges beyond primary ovarian insufficiency.

Authors:  Luis R Hoyos; Mili Thakur
Journal:  J Assist Reprod Genet       Date:  2016-12-19       Impact factor: 3.412

7.  Does the presence of AGG interruptions within the CGG repeat tract have a protective effect on the fertility phenotype of female FMR1 premutation carriers?

Authors:  M Friedman-Gohas; M Kirshenbaum; A Michaeli; N Domniz; S Elizur; H Raanani; R Orvieto; Y Cohen
Journal:  J Assist Reprod Genet       Date:  2020-02-24       Impact factor: 3.412

8.  Psychological status in female carriers of premutation FMR1 allele showing a complex relationship with the size of CGG expansion.

Authors:  D Z Loesch; M Q Bui; E Hammersley; A Schneider; E Storey; P Stimpson; T Burgess; D Francis; H Slater; F Tassone; R J Hagerman; D Hessl
Journal:  Clin Genet       Date:  2014-02-17       Impact factor: 4.438

Review 9.  Unstable mutations in the FMR1 gene and the phenotypes.

Authors:  Danuta Loesch; Randi Hagerman
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

10.  Improved methodology for assessment of mRNA levels in blood of patients with FMR1 related disorders.

Authors:  David E Godler; Danuta Z Loesch; Richard Huggins; Lavinia Gordon; Howard R Slater; Freya Gehling; Trent Burgess; K H Andy Choo
Journal:  BMC Clin Pathol       Date:  2009-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.